ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer

Figure 2

Kaplan-Meier survival curves of OS, DSS, DFI, and PFI in NSCLC. (a) OS analysis of ADGRD1 in LUAD. (b) DSS analysis of ADGRD1 in LUAD. (c) DFI analysis of ADGRD1 in LUAD. (d) PFI analysis of ADGRD1 in LUAD. (e) OS analysis of ADGRD1 in LUSC. (f) DSS analysis of ADGRD1 in LUSC. (g) PFI analysis of ADGRD1 in LUSC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)